利培酮

CAS号
1026102-43-1 ;106266-06-2
CCD编号
CCD00119130
分子式
C23 H27 F N4 O2
分子量
410.49

基本信息

产品名称: 利培酮
CAS: 1026102-43-1 ;106266-06-2
中文同义词: 3-[2-[4-(6-氟-1,2-苯并异噁唑-3-基)-1-哌啶]乙基]-6,7,8,9-四氢-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮 ; 利培酮
英文同义词: RISPERDAL CONSTA ; 3-[2-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-PIPERIDIN-1-YL]ETHYL]-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE ; SPIRON ; 3-(2-[4-(6-FLUORO-BENZO[D]ISOXAZOL-3-YL)-PIPERIDIN-1-YL]-ETHYL)-2-METHYL-6,7,8,9-TETRAHYDRO-PYRIDO[1,2-A]PYRIMIDIN-4-ONE ; RISPERIDONE ; RISPERIDONE EP IMPURITY E ; 3-[2-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL]ETHYL]-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE ; 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE, 3-[2-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL]ETHYL]-6,7,8,9-TETRAHYDRO-2-METHYL- ; RISPERIDAL ; RISPERIDONE EP IMPURITY I ; 4-[2-[4-(6-FLUOROBENZO[D]ISOXAZOL-3-YL)-1-PIPERIDYL]ETHYL]-3-METHYL-2,6-DIAZABICYCLO[4.4.0]DECA-1,3-DIEN-5-ONE ; RISPADAL ; RISPERDAL ; R 64 766 ; PSYCHODAL ; APEXIDONE ; 3-[2-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL]-6,7,8,9-TETRAHYDRO-2-METHYL-4H-PYRIDO [1,2-A] PYRIMIDIN-4-ONE
MDL号: MFCD00274576
氢键受体数量: 6
氢键供体数量: 0
Smile: Cc1c(c(=O)n2c(n1)CCCC2)CCN3CCC(CC3)c4c5ccc(cc5on4)F
InChi: InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
InChiKey: InChIKey=RAPZEAPATHNIPO-UHFFFAOYSA-N

性质

熔点: 172℃
注解: GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

安全信息

符号: GHS06 GHS06
信号词: Danger
危险声明: H301
警示性声明: P301 + P310
危害码: T
风险声明: R:25
安全声明: S:28-36-45
WGK德国: 3

* If the product has intellectual property rights, a license granted is must or contact us.